US Gene therapy Market
Gene therapy holds transformational potential by targeting genetic diseases at their root. In the U.S., the gene therapy market is expanding rapidly, backed by both established biopharma and nimble biotech startups focusing on rare genetic disorders, oncology, and regenerative medicine.
Major drivers include advancements in viral vectors (AAV, lentivirus), gene-editing technologies (CRISPR, base editors), and more favorable regulatory frameworks (notably FDA’s increasing gene therapy guidance). Also, increasing investment and collaborations are fueling pipeline growth.
3 Views